Skip to content

Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.

Anne C Wagner, Michael C Mithoefer, Ann T Mithoefer, Candice M Monson

Journal of Psychoactive Drugs 2019 DOI: 10.1080/02791072.2019.1589028 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Pilot study Case report Peer reviewed
Sample size 2
Population One couple with PTSD and a severe trauma history, participating in a pilot trial combining CBCT and MDMA
Interventions Cognitive Behavioral Conjoint Therapy for PTSD (CBCT) MDMA
Topics MDMA PTSD
Keywords Cbt PTSD Treatment Couples therapy MDMA Therapy
Citations 92
Key findings Combining CBCT for PTSD with MDMA-assisted psychotherapy can produce reductions in PTSD symptoms and improvements in relationship satisfaction.

Abstract

Treatments for posttraumatic stress disorder (PTSD) have evolved significantly in the past 35 years. From what was historically viewed as a pervasive, intractable condition have emerged multiple evidence-based intervention options. These treatments, predominantly cognitive behavioral in orientation, provide significant symptom improvement in 50-60% of recipients. The treatment of PTSD with MDMA-assisted psychotherapy using a supportive, non-directive approach has yielded promising results. It is unknown, however, how different therapeutic modalities could impact or improve outcomes. Therefore, to capitalize on the strengths of both approaches, Cognitive Behavioral Conjoint Therapy for PTSD (CBCT) was combined with MDMA in a small pilot trial. The current article provides a case study of one couple involved in the trial, chosen to provide a demographically representative example of the study participants and a case with a severe trauma history, to offer a detailed account of the methodology and choices made to integrate CBCT and MDMA, as well as an account of their experience through the treatment and their treatment gains. This article offers a description of the combination of CBCT for PTSD and MDMA, and demonstrates that it can produce reductions in PTSD symptoms and improvements in relationship satisfaction.

Comparable studies

Other case reports and case series on MDMA for PTSD, most cited first.

Study Year Design Participants
MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial Participant of color with treatment-resistant PTSD from an open-label trial of MDMA-AT 2022 Mixed-methods case study n = 1
MDMA, Internal Family Systems therapy, and the Minnesota model in the resolution of C-PTSD-induced alcohol and diazepam addiction—A retrospective case study Man in his forties with alcohol and diazepam addiction and complex PTSD from childhood... 2023 Case study n = 1
New‐Onset Obsessive–Compulsive Symptoms After MDMA‐Assisted Psychotherapy in a Patient With Refractory PTSD: A Case Report 31-year-old woman with chronic PTSD, nondistressing childhood compulsions, and complex... 2026 Case study n = 1
Six Month Follow up of the one of the First Patients to Complete MDMA-Assisted Therapy for PTSD Outside of Clinical Trials in Australia: Implications for Translating Clinical Research to Clinical Practice Adult female with chronic PTSD, depression, and anxiety due to domestic violence 2024 Case report n = 1

Explore topics

By condition and practice